Published on Spencer Knight via LinkedIn Novartis is acquiring Regulus Therapeutics for up to $1.7 billion to expand its position in...

Published on Spencer Knight via LinkedIn The FDA has approved ZEVASKYN™, the first-ever autologous cell-based gene therapy for patients...

Published on Spencer Knight via LinkedIn Ferring Pharmaceuticals has emerged as a commercial frontrunner in gene therapy with the...

Published on Spencer Knight via LinkedIn Lisa Noble, 58, was given just two weeks to live after failing chemotherapy for B cell lymphoma....

Published on Spencer Knight via LinkedIn The NHS in England is fast-tracking a cancer vaccine trial for melanoma through its Cancer...

Published on Spencer Knight via LinkedIn Capstan Therapeutics has entered Phase 1 trials with CPTX2309, an in vivo CAR-T candidate that...

Published on Spencer Knight via LinkedIn Hospital Clínic Barcelona-IDIBAPS has become a European leader in academic CAR-T, treating over...

Published on Spencer Knight via LinkedIn Neurona Therapeutics has secured $102 million to push forward its cell therapy NRTX-1001, which...

Published on Spencer Knight via LinkedIn Atsena Therapeutics has secured an oversubscribed $150 million Series C round, led by Bain...

Published on Spencer Knight via LinkedIn Multiple gene editing breakthroughs were announced in a single week, signaling strong momentum...

Published on Spencer Knight via LinkedIn A 14-month-old boy named Tomas, born with a life-threatening liver disorder called OTC...

Published on Spencer Knight via LinkedIn AstraZeneca has acquired Belgian biotech EsoBiotec for $1 billion, including $425 million...

Published on Spencer Knight via LinkedIn Bristol Myers Squibb has acquired 2seventy bio in an all-cash deal worth $286 million, offering...

Published on Spencer Knight via LinkedIn Regeneron has announced a major milestone in pediatric gene therapy using its DB-OTO treatment....

Published on Spencer Knight via LinkedIn A gene therapy trial at Moorfields Eye Hospital in London has given four children born with...

Published on Spencer Knight via LinkedIn Between 2004 - 2009, 19 children with neuroblastoma joined a CAR-T clinical trial at Baylor...

Published on Spencer Knight via LinkedIn 21-year-old Sebastien Beauzile spent his life in constant pain from sickle cell disease, unable...

Published on Spencer Knight via LinkedIn CAR-T once promised a revolution, then came the cost, complexity, and clinical setbacks. Spencer...

Published on Spencer Knight via LinkedIn Sana Biotechnology has announced successful first-in-human results using HIP-engineered islet...

Published on Repligen Poster, Bioprocessing Summit (July 2023) With biologics becoming more complex and global manufacturing capacity...